Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Plays Up Police Role; “White Paper” Recaps Recent Enforcement Steps

Executive Summary

An FDA "White Paper" highlighting the agency's recent enforcement actions is part of a concerted effort to draw consumer, industry and media attention to the agency's role in policing industry
Advertisement

Related Content

Fair Remedy Or Illegal Penalty? FDA Disgorgement Authority Questioned
Fair Remedy Or Illegal Penalty? FDA Disgorgement Authority Questioned
FDA Enforcement Priorities Include Guidance On Detailing And Kickbacks
FDA Enforcement Priorities Include Guidance On Detailing And Kickbacks
FDA Inspections To Target 55% Of “High-Risk” Manufacturers In FY 2004
FDA Counterfeiting Task Force To Look At Tighter Wholesaler Licensing
FDA Objects To Novartis IBS Ads; Claims Are Zelnorm-Specific, Agency Says
Botox Cosmetic Warning Letter: FDA Frowns On Broad Claims, Wants Correction
Botox Cosmetic Warning Letter: FDA Frowns On Broad Claims, Wants Correction
FDA “Chief Messaging Officer” Pitts Will Centralize Agency Communications
Advertisement
UsernamePublicRestriction

Register

PS042082

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel